GSK251
GSK251 is a highly potent, highly selective, orally bioavailable inhibitor of PI3Kδ with a novel binding mode.
Product Specifications
UNSPSC
12352005
Target
PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gsk251.html
Purity
99.88
Solubility
DMSO : 62.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=S(C1=CC(N2CCOCC2)=CN=C1OC)(NC3=CC(C4=CC=C(CN5CCN(C(C)C)CC5)C=C4F)=NC=C3)=O
Molecular Formula
C29H37FN6O4S
Molecular Weight
584.71
References & Citations
[1]Down K, et al. Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding Mode. J Med Chem. 2021 Sep 23;64 (18) :13780-13792.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-132880/GSK251-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-132880/GSK251-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[2125968-05-8]
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15129824 1 Vial
Lentiviral human GPALPP1 shRNA (UAS) - Lentiviral human GPALPP1 shRNA (UAS, GFP) (25)
Ask
View Details 
SP-52272-5 0.5 mg
Mastoparan [Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Arg-Lys-Arg-Gln-Gln-NH2; MW 2846.5]
Ask
View Details 